GENE ONLINE|News &
Opinion
Blog

Can Regulations Measure up to the Progress of Precision Medicine in Taiwan? – An Interview With Dr. Johnsee Lee

by Joy Lin
Share To
Precision medicine is the opposite of the conventional one-size-fits-all medical approach. Also called personalized medicine, the field takes into account an individual's genes, lifestyle, and environment before giving them custom-made treatments.  

Molecular diagnostics, which includes genetic testing, plays an indispensable role in precision medicine, displaying a wide variety of uses ranging from detecting diseases to assessing health risks for individuals.

Precision medicine is gaining traction as healthcare providers acknowledge that every patient tends to respond more favorably to treatments tailored to their specific needs.

GeneOnline recently had the pleasure to interview Dr. Johnsee Lee for his insights on the field of precision medicine and its relevance in Taiwan. Dr. Lee is Chairman of the Taiwan Precision Medical and Molecular Diagnostics Association (PMMD). He is also President and CEO of Quark Biosciences, a diagnostics and precision medicine company.

GO Prime with only $1.49 now

LATEST
Novel RAGE Antagonist Stirs Hopes for Countering Diabetic Complications
2021-12-07
AstraZeneca Blocks Private Equity Buyout of Swedish Pharma Sobi
2021-12-06
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
How CDMOs are Restructuring the Biopharma Landscape – An Interview with Bobby Sheng
2021-12-06
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
EVENT
2021-12-13
63rd ASH ANNUAL MEETING AND EXPOSITION
Georgia, USA
2021-12-28
BIOHK2021
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!